|
Acute coronary syndromes
Citations 621-630 of 961 total displayed.
|
Past content
(since Jan 1999):
|
- Mini-Review: Expert Opinions
Vulnerable Atherosclerotic Plaque: A Multifocal Disease
- Ward Casscells, Morteza Naghavi, and James T. Willerson
Circulation 2003;107:2072-2075, doi:10.1161/01.CIR.0000069329.70061.68
[Full text]
- Mini-Review: Expert Opinions
The Emperor’s Clothes: In Search of the Vulnerable Plaque
- Dean J. Kereiakes
Circulation 2003;107:2076-2077, doi:10.1161/01.CIR.0000069942.72072.2E
[Full text]
- Clinical Investigations and Reports
Serum Level of the Antiinflammatory Cytokine Interleukin-10 Is an Important Prognostic Determinant in Patients With Acute Coronary Syndromes
- Christopher Heeschen, Stefanie Dimmeler, Christian W. Hamm, Stephan Fichtlscherer, Eric Boersma, Maarten L. Simoons, Andreas M. Zeiher for the CAPTURE Study Investigators
Circulation 2003;107:2109-2114; published online before print as doi:10.1161/01.CIR.0000065232.57371.25
[Abstract]
[Full text]
- Articles
Physical Activity in Relation to Cardiovascular Disease and Total Mortality Among Men With Type 2 Diabetes
- Mihaela Tanasescu, Michael F. Leitzmann, Eric B. Rimm, and Frank B. Hu
Circulation published April 28, 2003, doi:10.1161/01.CIR.0000066906.11109.1F
[Abstract]
- Articles
Anti-Platelet Factor 4/Heparin Antibodies. An Independent Predictor of 30-Day Myocardial Infarction After Acute Coronary Ischemic Syndromes
- R. Taylor Williams, Lakshmi V. Damaraju, Mary Ann Mascelli, Elliot S. Barnathan, Robert M. Califf, Maarten L. Simoons, Efthymios N. Deliargyris, and David C. Sane
Circulation published April 21, 2003, doi:10.1161/01.CIR.0000066696.57519.AF
[Abstract]
- Editorials
N-3 Fatty Acids: Priority for Post-Myocardial Infarction Clinical Trials
- Scott M. Grundy
Circulation 2003;107:1834-1836, doi:10.1161/01.CIR.0000059746.10326.09
[Full text]
- Brief Rapid Communications
Reduction of Major Adverse Cardiac Events With Intracoronary Compared With Intravenous Bolus Application of Abciximab in Patients With Acute Myocardial Infarction or Unstable Angina Undergoing Coronary Angioplasty
- Jochen Wöhrle, Olaf C. Grebe, Thorsten Nusser, Eyas Al-Khayer, Stefan Schaible, Matthias Kochs, Vinzenz Hombach, and Martin Höher
Circulation 2003;107:1840-1843; published online before print as doi:10.1161/01.CIR.0000066852.98038.D1
[Abstract]
[Full text]
- Correspondence
A Decade of Improvement in the Clinical Outcomes of Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease
- V.S. Srinivas, Maria Mori Brooks, Katherine M. Detre, Janet Johnston, Spencer B. King, III, Alice K. Jacobs, and David O. Williams
Circulation 2003;107:e88, doi:10.1161/01.CIR.0000064684.67277.D6
[Full text]
- Clinical Investigations and Reports
Interaction Between Soluble Thrombomodulin and Intercellular Adhesion Molecule-1 in Predicting Risk of Coronary Heart Disease
- Kenneth K. Wu, Nena Aleksic, Christie M. Ballantyne, Chul Ahn, Harinder Juneja, and Eric Boerwinkle
Circulation 2003;107:1729-1732; published online before print as doi:10.1161/01.CIR.0000064894.97094.4F
[Abstract]
[Full text]
- Brief Rapid Communications
Reduction of Major Adverse Cardiac Events With Intracoronary Compared With Intravenous Bolus Application of Abciximab in Patients With Acute Myocardial Infarction or Unstable Angina Undergoing Coronary Angioplasty
- Jochen Wöhrle, Olaf C. Grebe, Thorsten Nusser, Eyas Al-Khayer, Stefan Schaible;, Matthias Kochs, Vinzenz Hombach, and Martin Höher
Circulation published April 7, 2003, doi:10.1161/01.CIR.0000066852.98038.D1
[Abstract]
|
|
